Mindy M Cheng

Summary

Country: USA

Publications

  1. ncbi request reprint Systematic review of comparative effectiveness data for oncology orphan drugs
    Mindy M Cheng
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA 98195 7630, USA
    Am J Manag Care 18:47-62. 2012
  2. doi request reprint A network meta-analysis of therapies for previously untreated chronic lymphocytic leukemia
    Mindy M Cheng
    University of Washington, Department of Pharmacy, Box 357630, Seattle, WA 98195 7630, USA
    Cancer Treat Rev 38:1004-11. 2012

Detail Information

Publications2

  1. ncbi request reprint Systematic review of comparative effectiveness data for oncology orphan drugs
    Mindy M Cheng
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA 98195 7630, USA
    Am J Manag Care 18:47-62. 2012
    ..To systematically assess clinical and economic evidence for oncology orphan drugs marketed in the United States and to highlight the challenges and opportunities for evidence development within this pharmaceutical category...
  2. doi request reprint A network meta-analysis of therapies for previously untreated chronic lymphocytic leukemia
    Mindy M Cheng
    University of Washington, Department of Pharmacy, Box 357630, Seattle, WA 98195 7630, USA
    Cancer Treat Rev 38:1004-11. 2012
    ..Many of these therapies have been compared against chlorambucil, but have not been directly compared against each other. There is currently no agreed upon standard therapeutic regimen for treatment-naïve CLL...